SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-004619
Filing Date
2024-07-02
Accepted
2024-07-02 17:00:10
Documents
16
Period of Report
2024-07-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm   iXBRL 8-K 35638
2 CERTIFICATE OF AMENDMENT phio_ex0301.htm EX-3.1 8463
3 PRESS RELEASE ISSUED BY THE COMPANY ON JULY 2, 2024 phio_ex9901.htm EX-99.1 13705
7 GRAPHIC image_001.jpg GRAPHIC 2315
  Complete submission text file 0001683168-24-004619.txt   245404

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20240701.xsd EX-101.SCH 3021
5 XBRL LABEL FILE phio-20240701_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE phio-20240701_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3817
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 241096677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)